Xiamen, China, April 13, 2022 - Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685), an innovative commercial-stage in vitro diagnostic (IVD) company, and Beckman Coulter Life Sciences, a global leader in life sciences lab automation and innovation, announced a demonstrated application development agreement for the Biomek NGeniuS system.
The partnership will enable Amoy Diagnostics to develop new demonstrated applications on the Biomek NGeniuS Next Generation Library Prep System. The purpose-built liquid handler for NGS library preparation reduces manual transfers and the traditionally labor-intensive process of library construction.
“We are committed to accelerating application development and providing new, demonstrated NGS applications to further propel the research journey of our customers,” said Jason Lanie, Vice President and General Manager of the Biotechnology Business Unit at Beckman Coulter Life Sciences. “This is part of a robust series of development agreements which speak to the strength of the Biomek NGeniuS system coupled with the automation library preparation portfolio of partners like Amoy Diagnostics.”
“Together with Beckman, AmoyDx will bring advanced and reliable automated library preparation solutions for improving the quality and efficiency of NGS creation” Said Jiemin Luo, the Rotating General Manager of AmoyDx.
As part of the partnership agreement, Amoy Diagnostics will develop demonstrated applications specifically designed for the Biomek NGeniuS liquid handler, which will be available to all users via a first-of-its-kind electronic application library.
About Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co., Ltd. is a pioneer and globally leading company in the field of molecular diagnostics for precision oncology, focusing on companion diagnostics product development and commercialization. A rich product portfolio has been established with more than twenty products approved by China NMPA, EU authority, Japan MHLW, South Korea MFDS, etc. Patients in more than 60 countries are benefiting from AmoyDx products. With multiple technological platforms and full capability for companion diagnostics product development and commercialization, AmoyDx has become an important diagnostics partner of many pharmaceutical companies over the globe. For more information, please visit www.amoydiagnostics.com.
About Beckman Coulter Life Sciences
Life sciences. Research. Precision manufacturing. If your life’s calling is in any of these or related fields, you need to know Beckman Coulter Life Sciences. Our mission is to empower those seeking answers to life’s important scientific and healthcare questions. Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. Genomic reagents. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. Wherever people need answers, from prestigious universities and major pharmaceutical companies, to small biotech startups, food/beverage and electronics manufacturing facilities, you can find Beckman Coulter Life Sciences. For more details, visit beckman.com/contact-us
© 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.